Medios AG (id:2744 ILM1)
13.12 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 11/23/2024 12:50:59 AM)
Exchange closed, opens in 2 days 8 hours
0.46 EUR (0.46%)
-8.76 EUR (-8.76%)
-11.11 EUR (-11.11%)
-9.64 EUR (-9.64%)
-23.99 EUR (-23.99%)
-44.17 EUR (-44.17%)
2,524.00 EUR (2,524.00%)
118.67 EUR (118.67%)
About Medios AG
Market Capitalization 355.95M
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products. Medios AG was founded in 2016 and is headquartered in Berlin, Germany.
| Headquarters (address) |
Heidestrasse 9 Berlin 10557 Germany |
| Phone | 49 30 232 5668 00 |
| Website | https://www.medios.ag |
| Employees | 1,011 |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Ticker | ILM1 |
| Exchange | Xetra Frankfurt Stock Exchange |
| Currency | EUR |
| 52 week range | 12.64 - 18.50 |
| Market Capitalization | 355.95M |
| P/E trailing | 26.11 |
| P/E forward | 11.07 |
| Price/Sale | 0.194 |
| Price/Book | 0.703 |
| Beta | 1.06 |
| EPS | 0.530 |
| EPS Germany (ID:66, base:321) | 2.35 |